NIH funding by institute · Fiscal year 2026
National Center for Advancing Translational Sciences (NCATS) Grants and Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 26, 2026Data refreshed October 16, 2026Editorial standards
NCATS administered $643.9M in fiscal year 2026 across 282 award records to 87 institutions with $10M or more in NIH funding, up 3.4% from FY2025. Vanderbilt University Medical Center received the most, 3.6% of that total.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NCATS funding
$643.9M
+3.4% vs FY2025
Award records
282
Institutions funded
87
Recipients with $10M+ in NIH funding
Open or upcoming NOFOs
26
NCATS as lead or participating institute
Top NCATS-funded institutions, FY2026
| # | Institution | NCATS FY2026 | vs FY2025 | Awards | Share |
|---|---|---|---|---|---|
| 1 | Vanderbilt University Medical CenterNashville, TN | $23.0M | +1.1% | 6 | 3.6% |
| 2 | University of PittsburghPittsburgh, PA | $19.8M | +3.7% | 8 | 3.1% |
| 3 | Johns Hopkins UniversityBaltimore, MD | $19.7M | +0.6% | 6 | 3.1% |
| 4 | University of PennsylvaniaPhiladelphia, PA | $16.8M | +18.5% | 6 | 2.6% |
| 5 | University of North Carolina at Chapel HillChapel Hill, NC | $15.4M | −0.8% | 7 | 2.4% |
| 6 | Stanford UniversityStanford, CA | $15.2M | −1.3% | 5 | 2.4% |
| 7 | Weill Cornell MedicineNew York, NY | $14.2M | +15.8% | 4 | 2.2% |
| 8 | Icahn School of Medicine at Mount SinaiNew York, NY | $14.1M | +6.5% | 8 | 2.2% |
| 9 | Tufts University BostonBoston, MA | $13.8M | −0.2% | 5 | 2.1% |
| 10 | University of MichiganAnn Arbor, MI | $13.7M | −20.8% | 6 | 2.1% |
| 11 | University of Alabama at BirminghamBirmingham, AL | $13.4M | +9.5% | 6 | 2.1% |
| 12 | University of WashingtonSeattle, WA | $12.7M | −2.0% | 3 | 2.0% |
| 13 | Harvard Medical SchoolBoston, MA | $12.5M | +2.5% | 2 | 1.9% |
| 14 | University of California, San FranciscoSan Francisco, CA | $12.3M | +6.1% | 3 | 1.9% |
| 15 | Washington University in St. LouisSaint Louis, MO | $12.3M | +3.4% | 5 | 1.9% |
| 16 | Emory UniversityAtlanta, GA | $12.2M | +3.6% | 4 | 1.9% |
| 17 | NYU Grossman School of MedicineNew York, NY | $12.2M | +28.6% | 4 | 1.9% |
| 18 | University of California San DiegoLa Jolla, CA | $11.9M | −3.5% | 2 | 1.8% |
| 19 | Oregon Health & Science UniversityPortland, OR | $11.9M | −0.2% | 4 | 1.8% |
| 20 | University of California, Los AngelesLos Angeles, CA | $11.5M | −0.0% | 3 | 1.8% |
| 21 | Columbia University Health SciencesNew York, NY | $11.4M | −6.7% | 3 | 1.8% |
| 22 | Duke UniversityDurham, NC | $11.4M | −21.0% | 2 | 1.8% |
| 23 | Case Western Reserve UniversityCleveland, OH | $11.3M | +1.2% | 6 | 1.8% |
| 24 | University of Wisconsin-MadisonMadison, WI | $10.7M | −1.3% | 3 | 1.7% |
| 25 | Cincinnati Children's Hospital Medical CenterCincinnati, OH | $10.1M | +74.4% | 3 | 1.6% |
Showing the 25 largest of 87 institutions with NCATS funding.
Open and upcoming NCATS funding opportunities
NOFOs led by NCATS first, then those NCATS participates in, soonest due date first. Browse every NIH NOFO.
Next due Jan 28, 2027
Next due Jan 28, 2027
Next due Jan 28, 2027
Next due Jan 28, 2027
Next due Jan 28, 2027
- Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
PAR-25-122 · R03
Next due Feb 16, 2027
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
PAR-25-450 · R21
Next due Feb 17, 2027
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
PAR-25-442 · R21
Next due Feb 17, 2027
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
PAR-25-296 · UG3, UH3
Next due Feb 17, 2027
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
RFA-TR-25-002 · R21
Expires Jun 3, 2027
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
PA-25-080 · R13 · led by NIH
Next due Dec 12, 2026
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
PA-27-100 · R43, R44 · led by NIH
Next due Jan 5, 2027
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
PA-27-101 · R44 · led by NIH
Next due Jan 5, 2027
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
PA-27-102 · R41, R42 · led by NIH
Next due Jan 5, 2027
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
PAR-27-098 · SB1 · led by OD
Next due Jan 5, 2027
Showing 15 of 26. See all NCATS NOFOs.
Recent NCATS awards
The newest NCATS award notices among the institutions above, each linked to its NIH RePORTER record.
- Peroxisomal Disorders Consortium (opens NIH RePORTER)
Baylor College of Medicine · 1U54TR006478-01 · NCATS · Notice Sep 17, 2026
$1.3MU54
- Accelerating Translation from Comparative Effectiveness through Implementation and Dissemination in Acute Care Medicine (ACTIVATE) Platform (opens NIH RePORTER)
Albert Einstein College of Medicine · 1RC2TR005999-01 · NCATS · Notice Sep 14, 2026
$3.2MRC2
- CTSA Postdoctoral T32 at the University of Kentucky (opens NIH RePORTER)
University of Kentucky · 1T32TR006370-01 · NCATS · Notice Sep 14, 2026
$209KT32
- Subjective Cognitive Dysfunction in Adults with Systemic Lupus Erythematosus Across the Lifespan (opens NIH RePORTER)
Hospital for Special Surgery · 1R03TR005820-01A1 · NCATS · Notice Sep 14, 2026
$179KR03
- Advancing Scalable AI-Powered Clinical Decision Support for AUC-Guided Vancomycin Dosing in ICU Patients (opens NIH RePORTER)
Loyola University Chicago · 1R03TR006291-01 · NCATS · Notice Sep 14, 2026
$154KR03
- CTSA Postdoctoral T32 Program at Georgetown-Howard Universities Center for Clinical and Translational Sciences (opens NIH RePORTER)
Georgetown University · 1T32TR005739-01A1 · NCATS · Notice Aug 19, 2026
$207KT32
- Targeting GATA3 as a therapeutic strategy in Th2-driven diseases (opens NIH RePORTER)
Sanford Burnham Prebys Medical Discovery Institute · 1R21TR006419-01 · NCATS · Notice Jul 21, 2026
$536KR21
- Development of Small Molecules that Activate PTP1B and OtherPhosphatases (opens NIH RePORTER)
University at Albany · 1R21TR006405-01 · NCATS · Notice Jul 20, 2026
$430KR21
- Targeted lysosomal degradation of RNA (opens NIH RePORTER)
Tufts University Medford · 1R21TR006446-01 · NCATS · Notice Jul 7, 2026
$375KR21
- Assessment of Everolimus as a Therapy for Vici Syndrome in a Preclinical Model (opens NIH RePORTER)
Children's Mercy Kansas City · 1R21TR005180-01A1 · NCATS · Notice Apr 28, 2026
$450KR21
Questions about NCATS funding
- How much does NCATS fund?
- In fiscal year 2026, NCATS administered $643.9M across 282 award records to the 87 institutions on this page. These are the recipients with $10M or more in total NIH funding, so the figure is a large share of NCATS's extramural awards but not its full budget.
- Which institutions get the most NCATS funding?
- Vanderbilt University Medical Center ($23.0M), University of Pittsburgh ($19.8M), Johns Hopkins University ($19.7M) led NCATS funding in FY2026.
- How do I find an open NCATS funding opportunity?
- This page lists open and upcoming NOFOs where NCATS is the lead or a participating institute, with the next due date. Most investigator-initiated applications go through the NIH parent announcements instead, and are assigned to an institute after submission; contact a NCATS program officer before you apply to check fit.
More NIH funding rankings
By type
University and health systems
By NIH institute
All institutes · NCI · NIAID · NIA · NHLBI · NIGMS · NINDS · NIDDK · NIMH · OD · NICHD · NIDA · NEI · NIAMS · NIEHS · NHGRI · NIAAA · NIDCD · NIDCR · NIBIB · NIMHD · NCCIH · NINR · NLM · FIC
By state
California · New York · Massachusetts · Pennsylvania · Texas · North Carolina · Maryland · Illinois · Washington · Ohio · Michigan · Florida · Missouri · Connecticut · Georgia · Minnesota · Tennessee · Wisconsin · Virginia · Colorado · New Jersey · Indiana · Oregon · Arizona · Alabama · Utah · Rhode Island · South Carolina · Kentucky · District of Columbia · Louisiana · Iowa · Oklahoma · Kansas · Nebraska · New Hampshire · New Mexico · Maine · Arkansas · Delaware · Mississippi · Vermont · Hawaii · Montana · West Virginia · Puerto Rico · South Dakota · Nevada · Idaho · North Dakota · Alaska · Wyoming